There are a number of urinary tract disorders (including; Interstitial Cystitis [IC] and primarily, cancers) and gut or digestive system disorders (including; Celiac, Crohn’s, Ileitis, Ulcerative Colitis [UC], Irritable Bowel Syndrome [IBS] and a variety of cancers) that can result in urinary and fecal incontinence, respectively. Collectively, there are several million of these patients in the US alone (3-8 million women and 1-4 million men with IC; 76,960 new cases of bladder cancer diagnosed each year; 1.4 million with Crohn’s and IBD and 900,000 with UC) with approximately 3-5X as many patients located throughout the rest of the westernized countries of the world. Some number of these cases can become so severe (of course, especially with respect to cancers) that severe treatments are required. While many of these patients will require significant treatments to control the resulting incontinence, a certain subgroup of these patients will require even more radical surgical procedures collectively referred to as ostomies. The new severe incontinence treatment technology being presented by Precision Medical Devices (PMD) device that can be implanted in a 15 (to 20)-minute same day procedure, is designed, and expected to first optimally treat the severer cases of urinary incontinence (UI) while already working on the design of a follow-on device expected to optimally treat fecal incontinence (FI), which, ultimately will treat those with serious gut disorders and ostomies as the device is essentially a new bionic sphincter. Notwithstanding the substantial cost savings for these patients, the improvement of their quality-of-life (QoL) is incalculable.